Transcription factor E2F4 is an indicator of poor prognosis and is related to immune infiltration in hepatocellular carcinoma

Conclusion: E2F4 could serve as a novel biomarker for HCC diagnosis and prognosis prediction.

Source: Journal of Cancer - April 19, 2021 Category: Cancer & Oncology Authors: Qiuxian Zheng, Qiang Fu, Jia Xu, Xinyu Gu, Haibo Zhou, Chen Zhi Tags: Research Paper Source Type: research